AKT1 and coronary artery disorder: GIK, an effective prescription for coronary heart disease and other heart diseases clinically [9, 26, 27], has been shown to exert anti-inflammatory effects to attenuate the systemic inflammatory response in endotoxemia rats and humans by inactivating nuclear factor κB or the phosphoinositide 3-kinase/Akt signaling pathway [28].